MGIT | LJ | |||||||
---|---|---|---|---|---|---|---|---|
Positive | Negative | contaminated | Total | Positive | Negative | Contaminated | Total | |
New patient | 131 (14.4%) | 230 (25.3%) | 62 (6.7%) | 423 (46.5%) | 103 (11.3%) | 283 (31.2%) | 37 (4%) | 423 (46.9) |
MDR-TB follow up patient | 105 (11.6%) | 304 (33.5%) | 76 (8.3%) | 485 (53.5%) | 79 (8.7%) | 359 (39.8%) | 47 (5.2%) | 485 (53.4%) |